Cellular senescence can be established by the activation of two different tumor suppressor pathways: CDKN2A (p16)-RB (retinoblastoma) and TP53 (p53)–cyclin-dependent kinase inhibitor 1A (CDKN1A, p21). Here, TP53 is linked to neoplasm.